In vitro diagnostics (IVD) are diagnostic tests practiced in an artificial environment. The overall revenue of the Asia-Pacific IVD market accounted for about $10.7 billion in 2014, and is estimated to reach $15.3 billion by 2020, registering a CAGR of 6.5% over the forecast period. Check complete report @ http://www.marketintelreports.com/report/allied0076/in-vitro-diagnostics-ivd-asiapacific-market--opportunities-and-forecasts-2014--2020

1. In Vitro Diagnostics (IVD) Asia-Pacific Market by
Manufacturers, Regions, Type and Application,
Forecast to 2021
Published on – 01 March, 2016 | Number of pages : 180
Single User Price: $ 2850
Click Here To Check Complete Report
“In Vitro Diagnostics (IVD) Asia-Pacific Market by
Manufacturers, Regions, Type and Application, Forecast to
2021”

2. Avail more information from Sample
Brochure of report
In vitro diagnostics (IVD) are diagnostic tests practiced in an artificial environment. The overall
revenue of the Asia-Pacific IVD market accounted for about $10.7 billion in 2014, and is
estimated to reach $15.3 billion by 2020, registering a CAGR of 6.5% over the forecast period.
Considerable increase in the number of chronic and infectious diseases, growing awareness
towards healthcare solutions and technological advancements in healthcare industry largely
supplement the growth of this market. However, stringent regulatory policies and
reimbursements issues in few countries limit the growth of this market.
The rising demand for technologically advanced diagnostic devices, rise in GDP and per capita
income and rise in disposable incomes facilitate a huge potential for the IVD market in the Asia-
Pacific region.The Asia-Pacific IVD market is segmented based on technique, product type,
usability, application, end user and country. Based on technique, the market is segmented into
immunoassays, clinical chemistry, point-of-care, molecular diagnostics, hematology, coagulation,
microbiology and other clinical techniques. Point-of-care is the highest revenue-generating
segment in the overall IVD techniques market.

3. However, the molecular diagnostics is the fastest growing technique in the overall IVD techniques
market due to its ability to accurately detect the primary cause of the disease.Based on product
type, the market is segmented into instruments, reagents, data management systems and
services. Instruments segment holds the highest market share in the Asia-Pacific IVD market
followed by rapidly growing reagents segment. Reagents are largely used in various equipment
and play a key role in the overall diagnosis process. The usability segment is classified as
disposable and reusable IVD devices. Doctors and clinicians largely prefer disposable devices to
avoid infections; generating larger revenue in comparison to reusable devices.

4. The application segment is categorized into infectious diseases diabetes, cancer/oncology, cardiology,
autoimmune diseases, nephrology, drug testing, HIV/AIDS and others. Infectious diseases was the
highest revenue-generating segment in 2014 and would continue to maintain its position throughout
2020, due to the rise in incidences of infectious diseases.Hospitals and laboratories, academics, point-of-
care testing and others form the end users segment in the Asia-Pacific IVD market. Hospitals and
laboratories generate the highest revenue, followed by point-of-care. A significant rise in the number of
hospitals and laboratories across the Asia-Pacific region along with increased awareness about
developments in healthcare largely contribute to the growth of this segment.
Based on country, the Asia-Pacific IVD market is segmented into India, China, Japan, Australia, South
Korea and rest of the Asia-Pacific. Currently, China leads the Asia-Pacific IVD market, owing to the high
demand for testing in outpatient clinics, huge population base and rising medical insurance services by
the Chinese government. However, Australia and South Korea hold the significant market share due to
the well-supported reimbursement facilities and well-regulated IVD devices, which comes under the
regulation of medical devices.Key companies profiled in this market include Danaher Corporation, Roche
Diagnostics, Abbott Laboratories, Siemens Healthcare, Alere Inc., Affymetrix Inc., Becton, Dickinson and
Company, Bio-Rad Laboratories, BioMerieux, Vela Diagnostics and others. Product launch and
technological advancements are the few strategies adopted by the key players of IVD market. The
companies are currently focusing on innovative technologies such as automated and point-of-care IVD
devices.KEY BENEFITS:Extensive coverage of the Asia-Pacific IVD market including drivers, restraints and

5. opportunities would help professionals to better understand the market
behaviourThe projections in the report are made by analyzing the current market
trends and market potential for the period of 20142020A comprehensive analysis of
the market scenario in terms of technologies, applications, usability, product type
end users and geography helps identify the growth opportunities in the Asia-Pacific
IVD marketThe market attractiveness analysis for the Asia-Pacific IVD market
provides strategic assistance to the decision makersKey market players within the

6. Make an Inquiry
Before Buying
Asia-Pacific IVD market are profiled in the report and their strategies are analysed
thoroughly, which helps in understanding competitive outlook of this marketIN
VITRO DIAGNOSTICS MARKET KEY SEGMENTS:Asia-Pacific IVD market is segmented
into applications, technology, product type, usability, end user, and geography.By
TechniquesImmunoassaysClinical ChemistryPoint Of CareMicrobiologyMolecular
DiagnosticsWhole Blood GlucoseHematologyCoagulationOther clinical techniquesBy
Product TypeInstrumentsReagentsData management systemsServicesBy
UsabilityDisposable DevicesReusable DevicesBy ApplicationsInfectious
DiseasesDiabetesCancer/OncologyCardiologyAutoimmune DiseasesNephrologyDrug
TestingHIV/AIDSOthersBy End-UserHospitals and LaboratoriesAcademicsPoint of
Care TestingOthersBy CountriesChinaIndiaJapanAustraliaSouth KoreaOthers

7. In Vitro Diagnostics (IVD) Asia-Pacific Market by Manufacturers,
Regions, Type and Application, Forecast to 2021
A detailed qualitative analysis of the factors responsible for driving and restraining
growth of In Vitro Diagnostics (IVD) Asia-Pacific Market by Manufacturers, Regions,
Type and Application, Forecast to 2021 and future opportunities are provided in the
report.
Contact:
1-302-261-5343
sales@marketintelreports.com
www.marketintelreports.com
Click here to order a copy of In Vitro
Diagnostics (IVD) Asia-Pacific Market
Report